These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1240543)

  • 1. [The experimental and clinical studies on the urinary calculi with the special reference to the metabolism of uric acid. Report II: relationship between urinary uric acid excretion and recurrent urinary oxalate containing calculus formation with special reference to the prevention of recurrence of formation (author's transl)].
    Kawamura T
    Nihon Hinyokika Gakkai Zasshi; 1975 Oct; 66(10):661-71. PubMed ID: 1240543
    [No Abstract]   [Full Text] [Related]  

  • 2. [The experimental and clinical studies on the urinary calculi with the special reference to the metabolism of uric acid. Report I: clinical statistics of urolithiasis with special reference to the relationship of serum uric acid concentration and urinary uric acid excretion to the formation of urinary oxalate containing calculi (author's transl)].
    Kawamura T
    Nihon Hinyokika Gakkai Zasshi; 1975 Oct; 66(10):656-60. PubMed ID: 1240542
    [No Abstract]   [Full Text] [Related]  

  • 3. [Current status of prevention and therapy of urinary calculi and peroral chemo-litholysis with special attention to the relationship of increased excretion of uric acid in oxalate lithiasis].
    Leskovar P
    Z Urol Nephrol; 1980 Mar; 73(3):229-39. PubMed ID: 7434987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Renal electrolyte changes by allopurinol. A contribution in the prophylaxis of oxalic acid stones (author's transl)].
    Garke P; Terhorst B
    Urologe A; 1974 Jul; 13(4 Pt A):166-7. PubMed ID: 4212796
    [No Abstract]   [Full Text] [Related]  

  • 5. Does hyperuricosuria play a role in calcium oxalate lithiasis?
    Ettinger B
    J Urol; 1989 Mar; 141(3 Pt 2):738-41. PubMed ID: 2645432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Guidelines for prevention of recurrent urolithiasis (author's transl)].
    Zechner O
    Wien Klin Wochenschr; 1981 Oct; 93(20):619-24. PubMed ID: 7324473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary magnesium and oxalic acid excretion in patients with recurrent oxalate urolithiasis.
    Takasaki E
    Invest Urol; 1975 Jan; 12(4):251-4. PubMed ID: 1112654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of recurrent uric acid and calcium oxalate stones by administration of the xanthine oxidase inhibitors Milurit 100 and Milurit 300.
    Schneider HJ; Brundig P; Balogh A; Traeger A; Stein G; Fünfstück R
    Int Urol Nephrol; 1983; 15(2):121-9. PubMed ID: 6688800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical studies of the recurrence of urolithiasis (3). Influence of sodium intake on urinary excretion of calcium, uric acid, oxalate, phosphate and magnesium].
    Murayama T; Taguchi H
    Hinyokika Kiyo; 1988 Sep; 34(9):1537-41. PubMed ID: 3213789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Principles of directed prevention of urinary calculi].
    Burchardt P; Reinecke F
    Dtsch Med Wochenschr; 1976 Sep; 101(36):1326-30. PubMed ID: 8300
    [No Abstract]   [Full Text] [Related]  

  • 11. [Stress and risk of urolith formation. I. The influence of stress on lithogenous urinary substances (author's transl)].
    Brundig P; Berg W; Schneider HJ
    Urol Int; 1981; 36(3):199-207. PubMed ID: 7281375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of allopurinol treatment on the prevention of hyperuricosuric calcium oxalate lithiasis.
    Hofbauer J; Zechner O
    Eur Urol; 1988; 15(3-4):227-9. PubMed ID: 3215256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in urinary composition of calcium oxalate stone formers.
    Rahman B; Rahman MA
    Biomed Pharmacother; 1986; 40(3):108-10. PubMed ID: 3742009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical studies on the recurrence of urolithiasis: (1). Influence of diet on urinary excretion of the stone forming constituents].
    Murayama T; Taguchi H
    Hinyokika Kiyo; 1987 Sep; 33(9):1321-30. PubMed ID: 3434487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recurrent urolithiasis--analysis of its etiology and treatment].
    Murakami M; Yamaguchi K; Mori I; Naito H; Miyauchi T; Ito H; Shimazaki J
    Nihon Hinyokika Gakkai Zasshi; 1982 Nov; 73(11):1402-9. PubMed ID: 7154469
    [No Abstract]   [Full Text] [Related]  

  • 16. Allopurinol in the recurrence prevention of calcium oxalate lithiasis.
    Brien G; Bick C
    Eur Urol; 1977; 3(1):35-6. PubMed ID: 837952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of allopurinol on urinary oxalate excretion in stone formers.
    Scott R; Paterson PJ; Mathieson A; Smith M
    Br J Urol; 1978 Dec; 50(7):455-8. PubMed ID: 753494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allopurinol and thiazide effects on new urinary stone formed after discontinued therapy in patients with urinary stones.
    Kohri K; Kodama M; Katayama Y; Ishikawa Y; Takada M; Kataoka K; Katoh Y; Iguchi M; Kurita T
    Urology; 1990 Oct; 36(4):309-14. PubMed ID: 2219608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic treatment of uric acid calculi.
    Preminger GM
    Urol Clin North Am; 1987 May; 14(2):335-8. PubMed ID: 3576854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies on urinary oxalate. 2. Excretion of oxalic acid in patients with urinary calculi (author's transl)].
    Yachiku S; Iguchi M; Kohri K; Kurita T; Takemoto M; Itatani H
    Nihon Hinyokika Gakkai Zasshi; 1979 Mar; 70(3):291-9. PubMed ID: 439528
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.